{"id":"W3187545758","doi":"10.1136/bmjopen-2020-046588","title":"A phase 3 randomised study of enzalutamide plus leuprolide and enzalutamide monotherapy in high-risk non-metastatic hormone-sensitive prostate cancer with rising PSA after local therapy: EMBARK study design","year":2021,"lang":"en","type":"article","venue":"BMJ Open","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"Astellas Pharma; Pfizer","keywords":"Enzalutamide; Medicine; Prostate cancer; Androgen deprivation therapy; Placebo; Internal medicine; Prostate-specific antigen; Oncology; Urology; Radiation therapy; Prostatectomy; Hormone therapy; Cancer; Breast cancer; Pathology; Androgen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005615421,0.003337091,0.004178365,0.0006947986,0.000650226,0.001592201,0.002023369,0.00251659,0.01382156],"category_scores_gemma":[0.002553822,0.001080377,0.003013052,0.0008337513,0.001739934,0.001644377,0.0008057066,0.003873549,0.002230987],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001494861,"about_ca_system_score_gemma":0.002726657,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001888871,"about_ca_topic_score_gemma":0.004989598,"domain_scores_codex":[0.997726,0.001462857,0.0001049722,0.0003058913,0.000132241,0.0002679869],"domain_scores_gemma":[0.9982198,0.0004302458,0.0003888216,0.0001631708,0.000158702,0.000639246],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9853805,0.007997506,0.0002762542,0.0003804071,0.0005895059,0.0000380276,0.00002820436,0.000205065,0.001668423,0.000066005,0.0005015181,0.002868632],"study_design_scores_gemma":[0.9238641,0.07386772,0.0009960124,0.00002183295,0.0003834469,0.00002332454,0.00001697667,0.000134431,0.0001556332,0.00008392861,0.0004382533,0.00001434702],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"protocol","genre_scores_codex":[0.9506826,0.007033991,0.001521783,0.001375205,0.0009797091,0.02864791,0.004106224,0.0002756616,0.005376806],"genre_scores_gemma":[0.9143536,0.004776348,0.006354296,0.004029885,0.001249768,0.05072857,0.00498251,0.0001099298,0.01341513],"genre_candidate":"protocol","genre_consensus":null,"teacher_disagreement_score":0.01382156,"threshold_uncertainty_score":0.04623777,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05980164032402145,"score_gpt":0.4043480596106108,"score_spread":0.3445464192865894,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}